Switch theme
Sign up to access all valuation multiples
Dr Agarwal’s Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa.
2010
6.3K+
LTM Revenue $199M
LTM EBITDA $52.8M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dr Agarwals has a last 12-month revenue of $199M and a last 12-month EBITDA of $52.8M.
In the most recent fiscal year, Dr Agarwals achieved revenue of $154M and an EBITDA of $47.2M.
Dr Agarwals expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dr Agarwals valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $118M | $154M | XXX | XXX | XXX |
| Gross Profit | $36.0M | $53.2M | XXX | XXX | XXX |
| Gross Margin | 30% | 34% | XXX | XXX | XXX |
| EBITDA | $33.0M | $47.2M | XXX | XXX | XXX |
| EBITDA Margin | 28% | 31% | XXX | XXX | XXX |
| Net Profit | $4.4M | $10.9M | XXX | XXX | XXX |
| Net Margin | 4% | 7% | XXX | XXX | XXX |
| Net Debt | $20.4M | $26.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Dr Agarwals's stock price is INR 415 (or $5).
Dr Agarwals has current market cap of INR 131B (or $1.5B), and EV of INR 137B (or $1.6B).
See Dr Agarwals trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $1.5B | XXX | XXX | XXX | XXX | $0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Dr Agarwals has market cap of $1.5B and EV of $1.6B.
Dr Agarwals's trades at 8.0x LTM EV/Revenue multiple, and 30.0x LTM EBITDA.
Analysts estimate Dr Agarwals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Dr Agarwals and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.6B | XXX | XXX | XXX |
| EV/Revenue | 8.5x | XXX | XXX | XXX |
| EV/EBITDA | 31.1x | XXX | XXX | XXX |
| P/E | 150.9x | XXX | XXX | XXX |
| P/E/Growth | 4.1x | XXX | XXX | XXX |
| EV/FCF | -47.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDr Agarwals's NTM/LTM revenue growth is 22%
Dr Agarwals's revenue per employee for the last fiscal year averaged $24K, while opex per employee averaged $7K for the same period.
Over next 12 months, Dr Agarwals's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Dr Agarwals's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Dr Agarwals and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 31% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 43% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 49% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $24K | XXX | XXX | XXX | XXX |
| Opex per Employee | $7K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 30% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr Agarwals acquired XXX companies to date.
Last acquisition by Dr Agarwals was XXXXXXXX, XXXXX XXXXX XXXXXX . Dr Agarwals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Dr Agarwals founded? | Dr Agarwals was founded in 2010. |
| Where is Dr Agarwals headquartered? | Dr Agarwals is headquartered in India. |
| How many employees does Dr Agarwals have? | As of today, Dr Agarwals has 6.3K+ employees. |
| Is Dr Agarwals publicy listed? | Yes, Dr Agarwals is a public company listed on NSE. |
| What is the stock symbol of Dr Agarwals? | Dr Agarwals trades under AGARWALEYE ticker. |
| When did Dr Agarwals go public? | Dr Agarwals went public in 2025. |
| Who are competitors of Dr Agarwals? | Similar companies to Dr Agarwals include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Dr Agarwals? | Dr Agarwals's current market cap is $1.5B |
| What is the current revenue of Dr Agarwals? | Dr Agarwals's last 12-month revenue is $199M. |
| What is the current EBITDA of Dr Agarwals? | Dr Agarwals's last 12-month EBITDA is $52.8M. |
| What is the current EV/Revenue multiple of Dr Agarwals? | Current revenue multiple of Dr Agarwals is 8.0x. |
| What is the current EV/EBITDA multiple of Dr Agarwals? | Current EBITDA multiple of Dr Agarwals is 30.0x. |
| What is the current revenue growth of Dr Agarwals? | Dr Agarwals revenue growth between 2023 and 2024 was 31%. |
| Is Dr Agarwals profitable? | Yes, Dr Agarwals is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
